Does tumor necrosis factor-α preceed occurrence of microalbuminuria in type 1 diabetes mellitus children?

Diabetologia Doswiadczalna i Kliniczna

Volumn 6, Issue 3, 2006, Pages 131-136

  Myśliwiec, Małgorzata ^a   Zorena, Katarzyna ^a   Balcerska, Anna ^a   Myśliwska, Jolanta ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Children; Diabetes mellitus type 1; Microalbuminuria; NAG; TNF

Indexed keywords

BETA N ACETYLGALACTOSAMINIDASE; BETA N ACETYLHEXOSAMINIDASE A; BETA N ACETYLHEXOSAMINIDASE B; HEMOGLOBIN A1C; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYMURIA; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; SCHOOL CHILD;

EID: 33745845158     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Harvey J, Allagoa E. The long-term renal and retinal outcome of childhood-onset type 1 diabetes. Diabet Med 2004; 21: 26-31.
2. Jones CA, Leese GP, Kerr S et al. Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child 1998; 78: 518-523.
3. Price RG. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992; 38: 14-19.
4. Lorini R, Scaramuzza A, Cortona L, Valenti G, Annunzio G. Increased urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion in young insulin-dependent diabetic patients. Diab Res Clin Prac 1995; 29: 99-105.
5. Hashimoto R, Adachi H, Nishida H, Tsuruta M, Nomura G. Serum N-acetyl-β-D-glucosaminidase activity in predicting the development of hypertension. Hypertension 1995; 25: 1311-1314.
6. Westhuyzeh J, McGiffin DC, McCarty J, Fleming SJ. Tubular nephrotoxicity after cardiac surgery utilizing cardiopulmonary bypass. Clin Chim Acta 1994; 228: 123-132.
7. Balla AA, Salah AM, Abdalmotaal E et al. N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pédiatric patients with urolithiasis. Word J Urol 1998; 16: 413-416.
8. Boyle JR, Goodall S, Thomson JP, Bell PR. Endovascular AAA repair attenuates the inflammatory and renal responses associated with conventional surgery. J Endovasc Ther 2000; 7: 359-363.
9. Jones AP, Lock S, Griffiths KD. Urinary N-acetyl-beta-glucosaminidase activity in type 1 diabetes mellitus. Am Clin Biochem 1995; 32: 58-62.
10. Hsiao PH, Tsai WS, Tsai WY, Lee JS. Urinary N-acetyl-beta-D- glucosaminidase activity in children with insulin-dependent diabetes mellitus. Am J Nephrol 1996; 16: 300-303.
11. Ikenaga H, Suzuki H, Ishii N, Itoh H, Saruta J. Enzymuria in non-insulin-dependent diabetic patients-signs of tubular cell dysfunction. Clin Sci 1993; 84: 469-475.
12. Kordonouri J, Hartmann R, Muller C, Danne T, Weber B. Predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes. Horm Res 1998; 50: 23-27.
13. Nakamura A, Suzuki T, Kohsaka T. Renal tubular function modulates urinary levels of interleukin-6. Nephron 1995; 70: 416-420.
14. Sheena MC, Gormley F, William T, McBride MD, Marilyn A, Armstrong G. Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery. Anesthesiology 2000; 93: 1210-1216.
15. Erbagci AB, Trackioglu M, Coskun Y, Sivasli E, Namiduru ES. Mediators of inflammation in children with type 1 diabetes mellitus: cytokines in type 1 diabetic children. Clin Bioch 2001; 34: 645-650.
16. Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes. Diabetes Care 2003; 26: 2165-2173.
17. American Diabetes Association Diagnosis and Classification of Diabetes. Diabetes Care 1997; 20: 1183-1197
18. and Diabetes Care 2003; 26: 3160-3167.
19. Myśliwska J, Zorena K, Ba̧kowska A, Skuratowicz-Kubica A, Myśliwski A. Significance of tumor necrosis factor alpha in patients with standing type-I diabetes mellitus. Norm Metab Res 1998; 3: 158-161.
20. Myśliwiec M, Balcerska A, Zorena K. The study on the activity of N-acetyl-beta-D-glucosaminidase (NAG) and its A and B isoenzymes in blood serum and urine as early indicators of vascular change development in the course of diabetes type 1 in children. Nefrologia i Dializoterapia Polska 2004; 2: 60-65.
21. Myśliwiec M, Balcerska A, Zorena K et al. Relationship between the level of TNFα, IL6 and risk of renal proximal tubules damage in children with newly diagnosed diabetes mellitus type 1. Polish Journal of Environmental Studies 2005 (suppl II): 292-295.
22. Cavalo MG, Pozzilli P, Bird C et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 1991; 86: 256-259.
23. Foss MC, Foss NT, Paccola GM, Silva CT. Serum levels of tumor necrosis factor in insulin-dependent diabetic patients (Abstract). Braz J Med Biol Res 1992; 3: 239-242.
24. Chatterjee PK, Hawksworth GM, McLay JS. Cytokine-stimulated nitric oxide production in the human renal proximal tubule and its modulation by natriuretic peptides: A novel immunomodulatory mechanism? Exp Nephrol 1999; 7: 438-448.
25. Markewitz BA, Michael JR, Kohan DE. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 1993; 91: 2138-2143.